Announcements Trials
Browse Landscape

Status

No longer available 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

PSR Ovarian Cancer With a BRCA Mutation 1Ovarian Neoplasms 1Ovarian Diseases 1Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

olaparib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Expanded_access × PSR Ovarian Cancer With a BRCA Mutation × olaparib × Clear all
NCT03063710 2018-05-17

Olaparib Expanded Access Program for BRCA Mutated Platinum Sensitive Relapsed High Grade Epithelial Ovarian Cancer Patients in Japan

AstraZeneca

No longer available
Gynecologic

PSR Ovarian Cancer With a BRCA Mutation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡